ClinConnect ClinConnect Logo
Search / Trial NCT04268927

Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET

Launched by CAIRO UNIVERSITY · Feb 12, 2020

Trial Information

Current as of April 25, 2025

Unknown status

Keywords

Letrozole ,Ivf, Poor Responders , Gn Rh Antagonist

ClinConnect Summary

Poor response to controlled ovarian stimulation (COH) is estimated to occur in 9-24 % of all IVF cycles. Although there is no consensus on the definition of poor response to COH, inability to produce adequate number of mature follicles( ≤ 2-5) or to recruit adequate number of oocytes ( ≤ 3 oocytes ) in response to standard stimulation protocols are the main criteria used for diagnosis of poor responders .

Patients with poor response to COH usually have higher cyclical cancelation rate , poor embryo quality and less number of embryos suitable for transfer or cryopreservation .

During the p...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Poor responders according to the ESHRE Bologna criteria
  • Exclusion Criteria:
  • Age \> 42 years FSH\> 12 IU/L Irregular menstrual cycles Unilateral ovary Polycystic ovary syndrome Endometriosis Male factor of infertility requiring ICSI History of recurrent miscarriage Endocrinologic disorders Systemic disease contraindicating pregnancy

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Giza, , Egypt

Patients applied

0 patients applied

Trial Officials

Usama M Fouda, Prof

Study Chair

Cairo University

Usama M Fouda, Prof

Study Chair

Riyadh Fertility and Reproductive Health center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials